Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions

Eur Heart J. 2015 Dec 1;36(45):3189-98. doi: 10.1093/eurheartj/ehv450. Epub 2015 Sep 2.

Abstract

Background: Through contemporary literature, the optimal strategy to manage coronary chronic total occlusions (CTOs) remains under debate.

Objectives: The aim of the Italian Registry of Chronic Total Occlusions (IRCTO) was to provide data on prevalence, characteristics, and outcome of CTO patients according to the management strategy.

Methods: The IRCTO is a prospective real world multicentre registry enrolling patients showing at least one CTO. Clinical and angiographic data were collected independently from the therapeutic strategy [optimal medical therapy (MT), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG)]; a comparative 1-year clinical follow-up was performed.

Results: A total of 1777 patients were enrolled for an overall CTO prevalence of 13.3%. The adopted therapeutic strategies were as follows: MT in 826 patients (46.5%), PCI in 776 patients (43.7%), and CABG in the remaining 175 patients (9.8%). At 1-year follow-up, patients undergoing PCI showed lower rate of major adverse cardiac and cerebrovascular events (MACCE) (2.6% vs. 8.2% and vs. 6.9%; P < 0.001 and P < 0.01) and cardiac death (1.4% vs. 4.7% and vs. 6.3%; P < 0.001 and P < 0.001) in comparison with those treated with MT and CABG, respectively. After propensity score-matching analysis, patients treated with PCI showed lower incidence of cardiac death (1.5 vs. 4.4%; P < 0.001), acute myocardial infarction (1.1 vs. 2.9%; P = 0.03), and re-hospitalization (2.3 vs. 4.4% P = 0.04) in comparison with those managed by MT.

Conclusions: Our data showed how CTO PCI might significantly improve the survival and decrease MACCE occurrence at 1 year follow-up in comparison with MT and/or CABG.

Keywords: CABG; Chronic total occlusion; Optimal medical therapy; PCI; Registry.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiovascular Agents / therapeutic use
  • Chronic Disease
  • Coronary Angiography / mortality
  • Coronary Artery Bypass / mortality
  • Coronary Artery Bypass / statistics & numerical data
  • Coronary Occlusion / mortality
  • Coronary Occlusion / therapy*
  • Female
  • Humans
  • Italy / epidemiology
  • Male
  • Percutaneous Coronary Intervention / mortality
  • Percutaneous Coronary Intervention / statistics & numerical data
  • Prevalence
  • Prospective Studies
  • Registries
  • Treatment Outcome
  • Ventricular Dysfunction, Left / mortality
  • Ventricular Dysfunction, Left / therapy

Substances

  • Cardiovascular Agents